Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Zongertinib for Lung Cancer
Recruiting2 awardsPhase 3
Springfield, Missouri
"This trial is looking for adults with advanced lung cancer who have not yet received chemotherapy. The study aims to see if a new medication called BI 1810631 (zongertinib) can
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service